Inhibition of Shh signaling is widely researched because aberrant Shh signaling is a hallmark of many cancers [6,7,8], including prostate, gallbladder, pancreatic, and basal cell carcinoma [9,10,11,12]. This evidence concerns the gene SHH and cancer.